Paglinawan, Silvestra D.

HRN: 22-86-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2023
CEFUROXIME 750MG (VIAL)
04/14/2023
04/21/2023
IV
750 Mg
Q8hrs
UTI

 Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Non-compliant To Guidelines